Discontinuation Versus Continuation of Renin-Angiotensin-system Inhibitors in COVID-19 (ACEI-COVID): a Prospective, Parallel Group, Randomised, Controlled, Open-Label Trial Axel Bauer , Michael Schreinlechner , Nikolay Sappler , Theresa Dolejsi , Herbert Tilg , Benedikt A. Aulinger , Guenter Weiss , Rosa Bellmann-Weiler , Christian Adolf , Dominik Wolf , Markus Pirklbauer , Ivo Graziadei , Hannes Gaenzer , Christian von Bary , Andreas E. May , Ewald Woell , Wolfgang von Scheidt , Tienush Rassaf , Daniel Duerschmied , Christoph Brenner , Stefan Kaeaeb , Bernhard Metzler , Michael Joannidis , Hans-Ulrich Kain , Norbert Kaiser , Robert Schwinger , Bernhard Witzenbichler , Hannes Alber , Florian Straube , Niels Hartmann , Stephan Achenbach , Michael von Bergwelt-Baildon , Lukas von Stuelpnagel , Sebastian Schoenherr , Lukas Forer , Sabine Embacher-Aichhorn , Ulrich Mansmann , Konstantinos D. Rizzast , Steffen Massberg The Lancet Respiratory medicine（2021）
AI 理解论文
溯源树
样例
